Drug Information

Drug General Information
Drug ID
D0W6GE
Former ID
DNC006587
Drug Name
N-(naphthalen-1-yl)-4-neopentylthiazol-2-amine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528047]
Structure
Download
2D MOL

3D MOL
Formula
C18H20N2S
Canonical SMILES
CC(C)(C)CC1=CSC(=N1)NC2=CC=CC3=CC=CC=C32
InChI
1S/C18H20N2S/c1-18(2,3)11-14-12-21-17(19-14)20-16-10-6-8-13-7-4-5-9-15(13)16/h4-10,12H,11H2,1-3H3,(H,19,20)
InChIKey
RIPVNQXJGQJLHV-UHFFFAOYSA-N
PubChem Compound ID
9922232
Target and Pathway
Target(s) C-Cchemokine receptor type 4 Target Info Inhibitor [528047]
KEGG Pathway Cytokine-cytokine receptor interaction
Chemokine signaling pathway
Viral carcinogenesis
PANTHER Pathway Inflammation mediated by chemokine and cytokine signaling pathway
Reactome Chemokine receptors bind chemokines
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 528047Bioorg Med Chem Lett. 2006 May 15;16(10):2800-3. Epub 2006 Feb 23.Optimization of 2-aminothiazole derivatives as CCR4 antagonists.
Ref 528047Bioorg Med Chem Lett. 2006 May 15;16(10):2800-3. Epub 2006 Feb 23.Optimization of 2-aminothiazole derivatives as CCR4 antagonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.